Restricted accessResearch articleFirst published online 2011-6
Potential of Electron Beam Computed Tomography for Coronary Artery Calcium Screening to Evaluate Fatty Liver: Comparison with 1H Magnetic Resonance Spectroscopy in the Dallas Heart Study
Electron beam computed tomography (EBCT) for coronary artery calcification can potentially evaluate liver fat, another marker of cardiovascular risk. We compared quantitative estimates of hepatic steatosis measured by EBCT with those obtained by a well-validated, accurate-measure, magnetic resonance spectroscopy (1H MRS).
Methods
EBCT and 1H MRS were performed in 2159 subjects from the Dallas Heart Study. Forty subjects were randomly selected from each of 5 subgroups of liver fat percent by 1H MRS (n = 200). EBCT average liver attenuation (HU) was determined in a 1- to 2-cm circular region of interest over the liver lobes. Pearson correlation coefficients were calculated. Using a previously defined 1H MRS hepatic steatosis cut point (>5.5%), an optimized EBCT liver attenuation cut point was determined by receiver operating characteristic analysis.
Results
1H MRS liver fat content and EBCT average right lobe liver attenuation were moderately negatively correlated (r = −0.64, P < 0.0001) in all subjects and in those with 1H MRS hepatic steatosis (r = −0.71, P < 0.0001). This correlation did not improve with attenuation correction of the EBCT data using a standard calcium phantom or statistical transformation. Using an optimized receiver operating characteristic EBCT cut point (64.5 HU), sensitivity was 78% and specificity was 72% for detecting 1H MRS hepatic steatosis, with a high false negative rate. Risk factors for hepatic steatosis (obesity, diabetes mellitus, insulin resistance, metabolic syndrome) were more strongly correlated with 1H MRS than EBCT liver fat measures.
Conclusions
Liver attenuation on EBCT acquired for coronary artery calcification screening correlates modestly with 1H MRS measures of liver fat content, with a high false negative rate.
AngelicoF, Del BenM, ContiR, . Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2005;90:1578–1582.
3.
TargherG, BertoliniL, PadovaniR, . Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;30:1212–1218.
4.
McClellandRL, ChungH, DetranoR, . Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2006;113:30–37.
5.
TaylorAJ, BindemanJ, FeuersteinI, . Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. J Am Coll Cardiol. 2005;46:807–814.
6.
PatelMJ, deLemos JA, McGuireDK, . Evaluation of coronary artery calcium screening strategies focused on risk categories: the Dallas Heart Study. Am Heart J. 2009;157:1001–1009.
7.
AssyN, DjibreA, FarahR, . Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology. 2010;254:393–400.
8.
SchwenzerNF, SpringerF, SchramlC, . Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol. 2009;51:433–445.
9.
SzczepaniakLS, NurenbergP, LeonardD, . Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005;288:E462–E468.
10.
LongoR, PolleselloP, RicciC, . Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging. 1995;5:281–285.
11.
LongoR, RicciC, MasuttiF, . Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol. 1993;28:297–302.
12.
SzczepaniakLS, BabcockEE, SchickF, . Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol. 1999;276:E977–E989.
13.
ThomsenC, BeckerU, WinklerK, . Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging. 1994;12:487–495.
14.
CowinGJ, JonssonJR, BauerJD, . Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging. 2008;28:937–945.
15.
ZhongL, ChenJJ, ChenJ, . Nonalcoholic fatty liver disease: quantitative assessment of liver fat content by computed tomography, magnetic resonance imaging and proton magnetic resonance spectroscopy. J Dig Dis. 2009;10:315–320.
SchererU, SantosM, LissnerJ.CT studies of the liver in vitro: a report on 82 cases with pathological correlation. J Comput Assist Tomogr. 1979;3:589–595.
18.
PamiloM, SotaniemiEA, SuramoI, . Evaluation of liver steatotic and fibrous content by computerized tomography and ultrasound. Scand J Gastroenterol. 1983;18:743–747.
19.
VictorRG, HaleyRW, WillettDL, . The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol. 2004;93:1473–1480.
20.
BrowningJD, SzczepaniakLS, DobbinsR, . Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387–1395.
21.
ChenK, LindseyJB, KheraA, . Independent associations between metabolic syndrome, diabetes mellitus and atherosclerosis: observations from the Dallas Heart Study. Diab Vasc Dis Res. 2008;5:96–101.
22.
JainT, PeshockR, McGuireDK, . African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study. J Am Coll Cardiol. 2004;44:1011–1017.
23.
KodamaY, NgCS, WuTT, . Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol. 2007;188:1307–1312.
24.
HoriguchiJ, NakanishiT, ItoK.Quantification of coronary artery calcium using multidetector CT and a retrospective ECG-gating reconstruction algorithm. AJR Am J Roentgenol. 2001;177:1429–1435.
25.
YoonDY, MoonJH, KimHK, . Comparison of low-dose CT and MR for measurement of intra-abdominal adipose tissue: a phantom and human study. Acad Radiol. 2008;15:62–70.
26.
vanWervenJR, MarsmanHA, NederveenAJ, . Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology. 2010;256:159–168.
27.
ParkSH, KimPN, KimKW, . Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology. 2006;239:105–112.
28.
RicciC, LongoR, GioulisE, . Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 1997;27:108–113.
29.
BydderGM, KreelL, ChapmanRW, . Accuracy of computed tomography in diagnosis of fatty liver. Br Med J. 1980;281:1042.
30.
MachannJ, ThamerC, SchnoedtB, . Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med. 2006;55:913–917.
31.
YokooT, BydderM, HamiltonG, . Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology. 2009;251:67–76.
32.
PiekarskiJ, GoldbergHI, RoyalSA, . Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology. 1980;137:727–729.
33.
LimanondP, RamanSS, LassmanC, . Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology. 2004;230:276–280.
34.
BudoffMJ, MaoS, LuB, . Ability of calibration phantom to reduce the interscan variability in electron beam computed tomography. J Comput Assist Tomogr. 2002;26:886–891.
35.
ChauA, GopalA, MaoS, . Comparison of three generations of electron beam tomography on image noise and reproducibility, a phantom study. Invest Radiol. 2006;41:522–526.
36.
DavidsonLE, KukJL, ChurchTS, . Protocol for measurement of liver fat by computed tomography. J Appl Physiol. 2006;100:864–868.
37.
SpeliotesEK, MassaroJM, HoffmannU, . Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. J Gastroenterol Hepatol. 2008;23:894–899.
38.
DingJ, KritchevskySB, HsuFC, . Association between non-subcutaneous adiposity and calcified coronary plaque: a substudy of the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr. 2008;88:645–650.
39.
UedaJ, KobayashiY, KenkoY, . Distribution of water, fat, and metals in normal liver and in liver metastases influencing attenuation on computed tomography. Acta Radiol. 1988;29:33–39.
40.
DumanDG, CelikelC, TuneyD, . Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment?Dig Dis Sci. 2006;51:346–351.
41.
IshikawaI, TateishiK, ShinodaA, . Changes of the hepatic CT absorption value in hemodialysis patients. J Comput Assist Tomogr. 1984;8:701–703.
42.
McKenzieA, GillG, McIntoshR, . Computed tomographic and ultrasound appearances of focal spared areas in fatty infiltration of the liver. Australas Radiol. 1991;35:166–168.
43.
OlivaMR, MorteleKJ, SegattoE, . Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation. J Comput Assist Tomogr. 2006;30:37–43.
